Prevalence and interrelationships between cardio-metabolic risk factors in abdominally obese individuals

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 1, 2009, Pages 31-36

  Pettman, Tahna L ^a,b   Buckley, Jonathan D ^a   Coates, Alison M ^a   Misan, Gary M H ^a,b   Petkov, John ^a   Howe, Peter R C ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Spencer Gulf Rural Health School   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; AUSTRALIA; BLOOD; CLUSTER ANALYSIS; DYSLIPIDEMIAS; HYPERGLYCEMIA; METABOLISM; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; POISSON DISTRIBUTION; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

GLUCOSE BLOOD LEVEL; LIPID;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CLUSTER ANALYSIS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; LIPIDS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; ODDS RATIO; POISSON DISTRIBUTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SOUTH AUSTRALIA; WAIST CIRCUMFERENCE;

EID: 84950170948     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0047     Document Type: Article

References (25)

1. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Expert Panel of Detection Evaluation and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
3. Alberti G: Introduction to the metabolic syndrome. Eur Heart J Suppl 2005;7(suppl-D):D3-D5.
4. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation; 2005.
5. Karelis AD, M Brochu M, Rabasa-Lhoret R: Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004;30:569-572.
6. Sims EAH: Are there persons who are obese, but metabolically healthy? Metabolism 2001;50:1499-1504.
7. Australian Bureau of Statistics: National Health Survey: Summary of Results 2004-05. Commonwealth of Australia; 2006.
8. Ford ES, Giles WH, Dietz, WH: Prevalence of the metabolic syndrome among US adults: findings From the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
9. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Sr, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167.
10. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE: The metabolic syndrome in Australia: Prevalence using four definitions. Diabetes Res Clin Pract 2007;77:471-478.
11. Janus ED, Laatikainen T, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B, Tideman PA, Tirimacco R, Heistaro S: Overweight, obesity and metabolic syndrome in rural southeastern Australia. MJA 2007;187:147-152.
12. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, Kuller LH, for the Multiple Risk Factor Intervention Trial Research, G, Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care 2006;29:123-130.
13. Prabhakaran D, Anand SS: The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 2004;9:55-68.
14. Alberti KGMM, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. The Lancet 2005;366:1059.
15. National Heart Foundation of Australia: Lipid Management Guidelines - 2001. MJA 2001;175(Suppl):S57-S88.
16. Fausett L: Fundamentals of Neural Networks: Architectures, Algorithms, and Applications, ed. F. Laurene. Prentice-Hall, Inc.; 461:1994.
17. Simon H: Neural Networks: A Comprehensive Foundation. Prentice Hall PTR; 768:1994.
18. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-1649.
19. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EAH, Poehlman ET: What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
20. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250.
21. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres J-P: Total cholesterol/ HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: The Quebec Cardiovascular Study. Arch Intern Med 2001;161:2685-2692.
22. Marks DB, Marks AD, Smith CM: Basic Medical Biochemistry. Baltimore, MD: Williams & Wilkins; 1996.
23. Wierzbicki AS: Lipid lowering: another method of reducing blood pressure? J Hum Hypertens 2002;16:753-760.
24. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S: Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004;93:159-164.
25. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M-R, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.